The firm also won a patent infringement case against Teva Pharmaceuticals USA Inc., the generic-drug maker seeking to produce a Singulair copy to sell. ...
For example, the price of these drugs increased: I was on Singulair last year for asthma. I found that I could get it in Canada for half what I would pay ...
An even bigger blow looms in 2012, when asthma treatment Singulair -- the company's biggest product with annual sales of $4.5 billion -- faces cheaper ...
s asthma drug Singulair, with $4.7 billion in sales, and blood pressure drug Cozaar with $3.4 billion; and Pfizer antidepressant Effexor, with $4.3 billion ...
